Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease

Genes and Immunity

Volumn 17, Issue 5, 2016, Pages 298-304

  Long, D ^a   Deng, X ^a,b   Singh, P ^c   Loeb, M ^c   Lauring, A S ^d   Seielstad, M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; HLA A ANTIGEN; HLA DQB1 ANTIGEN; SPACER DNA; CACNA1H PROTEIN, HUMAN; CALCIUM CHANNEL T TYPE; HERC5 PROTEIN, HUMAN; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; IMMUNOGLOBULIN; JARID2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; REPRESSOR PROTEIN; SIGNAL PEPTIDE; TFCP2L1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CACNA1H GENE; COHORT ANALYSIS; CONTROLLED STUDY; EXOME; FEMALE; GENE; GENE LOCUS; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HERC5 GENE; HUMAN; IMMUNE RESPONSE; JARID2 GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TFCP2L1 GENE; WEST NILE NEUROINVASIVE DISEASE; WEST NILE VIRUS; AGED; CASE CONTROL STUDY; GENETICS; WEST NILE FEVER;

ADULT; AGED; ANTIGENS, CD; CALCIUM CHANNELS, T-TYPE; CASE-CONTROL STUDIES; FEMALE; GENETIC LOCI; HLA-DQ BETA-CHAINS; HUMANS; IMMUNOGLOBULINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYCOMB REPRESSIVE COMPLEX 2; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; WEST NILE FEVER;

EID: 84966570032     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2016.21     Document Type: Article

References (46)

1. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA 2013; 310: 308-315.
2. West Nile http://www.cdc.gov/westnile/ (accessed 3 June 2015).
3. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261-264.
4. Chowers MY, Lang R, Nassar F, Ben-David D, Giladi M, Rubinshtein E et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging Infect Dis 2001; 7: 675-678.
5. Patnaik JL, Harmon H, Vogt RL. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerging Infect Dis 2006; 12: 1129-1131.
6. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006; 42: 1234-1240.
7. Weiss D, Carr D, Kellachan J, Tan C, Phillips M, Bresnitz E et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerging Infect Dis 2001; 7: 654-658.
8. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344: 1807-1814.
9. Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerging Infect Dis 2007; 13: 1918-1920.
10. Samuel CE. Host genetic variability and West Nile virus susceptibility. Proc Natl Acad Sci USA 2002; 99: 11555-11557.
11. Suthar MS, Diamond MS, Gale M. West Nile virus infection and immunity. Nat Rev Microbiol 2013; 11: 115-128.
12. Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 2009; 5: e1000321.
13. Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA et al. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 2005; 192: 1741-1748.
14. Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D et al. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 2010; 201: 178-185.
15. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 2006; 203: 35-40.
16. Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H et al. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One 2011; 6: e24745.
17. Loeb M, Eskandarian S, Rupp M, Fishman N, Gasink L, Patterson J et al. Genetic variants and susceptibility to neurological complications following West Nile virus infection. J Infect Dis 2011; 204: 1031-1037.
18. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012; 337: 64-69.
19. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, Verzilli C et al. An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 2012; 337: 100-104.
20. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
21. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, De Pristo MA, Durbin RM et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
22. Pelak K, Shianna KV, Ge D, Maia JM, Zhu M, Smith JP et al. The characterization of twenty sequenced human genomes. PLoS Genet 2010; 6: e1001111.
23. Biesecker LG. Exome sequencing makes medical genomics a reality. Nat Genet 2010; 42: 13-14.
24. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA et al. Optimal unified approach for rare-variant association testing with application to smallsample case-control whole-exome sequencing studies. Am J Hum Genet 2012; 91: 224-237.
25. Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR et al. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet 2012; 44: 886-889.
26. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.
27. Li L, Li Y, Browning SR, Browning BL, Slater AJ, Kong X et al. Performance of genotype imputation for rare variants identified in exons and flanking regions of genes. PLoS One 2011; 6: e24945.
28. Wang Z, Jacobs KB, Yeager M, Hutchinson A, Sampson J, Chatterjee N et al. Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet 2012; 44: 6-7.
29. Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for case-control genetic association analyses. BMC Genet 2008; 9: 36.
30. Hecker M, Goertsches RH, Fatum C, Koczan D, Thiesen H-J, Guthke R et al. Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment. Pharmacogenomics J 2012; 12: 360-360.
31. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y et al. Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum 2012; 64: 4104-4113.
32. Cain SM, Snutch TP. T-type calcium channels in burst-firing, network synchrony, and epilepsy. Biochim Biophys Acta 2013; 1828: 1572-1578.
33. Pasaniuc B, Rohland N, McLaren PJ, Garimella K, Zaitlen N, Li H et al. Extremely low-coverage sequencing and imputation increases power for genome-wide association studies. Nat Genet 2012; 44: 631-635.
34. Lam HYK, Clark MJ, Chen R, Chen R, Natsoulis G, O'Huallachain M et al. Performance comparison of whole-genome sequencing platforms. Nat Biotechnol 2012; 30: 78-82.
35. Heinzen EL, Depondt C, Cavalleri GL, Ruzzo EK, Walley NM, Need AC et al. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 2012; 91: 293-302.
36. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
37. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-2079.
38. De Pristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011; 43: 491-498.
39. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, Snp Eff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012; 6: 80-92.
40. Exome Variant Server. Available at http://evs.gs.washington.edu/EVS/ (accessed 30 May 2015).
41. NIEHS EGP - Exome Project. Available at http://egp.gs.washington.edu/ (accessed 30 May 2015).
42. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
43. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
44. Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
45. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
46. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ et al. Exome sequencing and the genetic basis of complex traits. Nat Genet 2012; 44: 623-630.